Activity of a newly identified serine protease in CNS demyelination

Brain

Volumn 125, Issue 6, 2002, Pages 1283-1296

  Scarisbrick, Isobel A ^a,d   Blaber, S I ^b   Lucchinetti, C F ^a   Genain, C P ^c   Blaber, M ^b   Rodriguez, M ^a  

^a MAYO CLINIC   (United States)

^b FLORIDA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MAYO CLINIC ROCHESTER   (United States)

Author keywords

Demyelination; Glia; Inflammation; Multiple sclerosis; Proteolytic enzyme

Indexed keywords

GREEN FLUORESCENT PROTEIN; MYELENCEPHALON SPECIFIC PROTEASE; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; RECOMBINANT ENZYME; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; DEMYELINATING DISEASE; ENZYME ACTIVITY; ENZYME SUBSTRATE; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MACROPHAGE; MARMOSET; MONONUCLEAR CELL; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STEM CELL; T LYMPHOCYTE;

EID: 0036266204     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awf142     Document Type: Article

References (65)

1. Degradation of myelin basic protein by cerebrospinal fluid: Preservation of antigenic determinants under physiological conditions
2. A novel protease homolog differentially expressed in breast and ovarian cancer
3. Demonstration of interleukin-1 beta in Lewis rat brain during experimental allergic encephalomyelitis by immunocytochemistry at the light and ultrastructural level
4. Enzymatic properties of rat myelencephalon-specific protease
5. Complement potentiates the degradation of myelin proteins by plasmin: Implications for a mechanism of inflammatory demyelination
6. Matrix metalloproteinases degrade myelin basic protein
7. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions
8. Proteolytic enzyme activity of blood leukocytes and cerebrospinal fluid in multiple sclerosis
9. The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: Comparison of stages in lesion evolution
10. Loss of hippocampal serine protease BSP1/neuropsin predisposes to global seizure activity
11. The contribution of phosphorylation and loss of COOH-terminal arginine to the microheterogeneity of myelin basic protein
12. Human kallikrein 6 as a biomarker of Alzheimer's disease
13. Human kallikrein 6 (zyme/protease M/neurosin): A new serum biomarker of ovarian carcinoma
14. Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications
15. Creation of a model for multiple sclerosis in Callithrix jacchus marmosets
16. In healthy primates, circulating autoreactive T cells mediate autoimmune disease
17. Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein
18. Serine proteases and brain damage - Is there a link?
19. Plasminogen activators in multiple sclerosis lesions: Implications for the inflammatory response and axonal damage
20. A serine protease inhibitor, protease nexin I, rescues motoneurons from naturally occurring and axotomy-induced cell death
21. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages
22. Temporal development of autoreactive Thl responses and endogenous antigen presentation of self myelin epitopes by central nervous system-resident APCs in Theiler's virus-infected mice
23. Matrix metalloproteinases in inflammatory demyelination: Targets for treatment
24. Immunopathology of multiple sclerosis: Report on an international meeting held at the Institute of Neurology of the University of Vienna
25. Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: A possible mechanism for treatment efficacy in multiple sclerosis
26. The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis
27. Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus
28. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system
29. Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain
30. Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction
31. Proteolytic activity, synapse elimination, and the Hebb synapse
32. Autocrine inhibition of mitotic activity in cultured oligodendrocyte-type-2 astrocyte (O-2A) precursor cells
33. Matrix metalloproteinases in the normal human central nervous system, microglia nodules, and multiple sclerosis lesions
34. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue
35. Immunologic aspects of Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease
36. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading
37. Cell-derived proteases and protease inhibitors as regulators of neurite outgrowth
38. Plasminogen activator-plasmin system and neuronal migration
39. Prevention of acute autoimmune encephalomyelitis and abrogation of relapses in murine models of multiple sclerosis by the protease inhibitor D-penicillamine
40. Multiple sclerosis
41. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis
42. Characterization of brain-related serine protease, neurosin (human kallikrein 6), in human cerebrospinal fluid
43. The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry
44. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
45. Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein
46. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines
47. Multiple sclerosis: Basic concepts and hypothesis
48. Tumor necrosis factor-alpha-induced gelatinase beta causes delayed opening of the blood-brain barrier: An expanded therapeutic window
49. Reactive oxygen species are invovled in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats
50. Nervous system-specific expression of a novel serine protease: Regulation in the adult rat spinal cord by excitotoxic injury
51. Differential expression of brain-derived neurotrophic factor, neurotrophin-3 and neurotrophin-4/5 in the adult rat spinal cord: Regulation by the glutamate receptor agonist kainic acid
52. Preferential expression of myelencephalon-specific protease by oligodendrocytes of the adult rat spinal cord white matter
53. MSP, a trypsin-like serine protease, is abundantly expressed in the human nervous system
54. Cerebellar granule cell migration involves proteolysis
55. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
56. Expression of the kallikrein gene family in normal and Alzheimer's disease brain
57. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: An immunocytological study in the central nervous system
58. Interferon beta-1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase-9
59. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice
60. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator
61. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus
62. Protease M/neurosin mRNA is expressed in mature oligodendroyctes
63. Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain
64. The new human tissue kallikrein gene family: Structure, function, and association to disease
65. Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease